Skip to main content
. Author manuscript; available in PMC: 2022 Feb 10.
Published in final edited form as: J Control Release. 2020 Nov 11;330:1095–1105. doi: 10.1016/j.jconrel.2020.11.014

Fig. 2.

Fig. 2.

Characterization of immuno-NPs. A) Schematic depicting the nanoparticle formulations. B) Loading of cdGMP and MPLA (μg per mmol lipid bilayer components) following 3 hours dialysis against PBS. C) Representative particle size measured by dynamic light scattering (DLS). D) ELISA of IFNβ production from murine RAW 264.7 macrophages following 24-hour exposure to immuno-NP formulations. Data is plotted as mean ± SD. Statistics for the ELISA were calculated using one-way ANOVA with Tukey’s post-test. **P < 0.01; ***P < 0.001; ****P < 0.0001